The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 25, 2014
Filed:
Jul. 17, 2013
King Fahd University of Petroleum and Minerals, Dhahran, SA;
King Abdulaziz City for Science and Technology, Riyadh, SA;
Anvarhusein Abdulkadir Isab, Dhahran, SA;
Mohammed Ismail Mohammed Wazeer, Dhahran, SA;
Said Salman Al-Jaroudi, Qatif, SA;
Saleh Abdulaziz Altuwaijri, Al-Khobar, SA;
King Fahd University of Petroleum and Minerals, Dhahran, SA;
King Abdulaziz City for Science and Technology, Riyadh, SA;
Abstract
The cytotoxic compounds are gold(III) complexes of the type [(diaminocyclohexane)AuCl]Cl, derived from sodium tetrachloroaurate(III) dihydrate NaAuCl.2HO. Specifically, the cytotoxic compounds are gold complexes of isomers of 1,2-diaminocyclohexane, namely cis-(±)-1,2-(diaminocyclohexane)AuCl, trans-(±)-1,2-(diaminocyclohexane)AuCland S,S-(+)-1,2-(diaminocyclohexane)AuCl. In order to treat cancer cells in a patient, such as human prostate cancer cells or human gastric cancer cells, an effective amount of the isomer of 1,2-(diaminocyclohexane)AuClis administered to the cancer cells in the patient. The isomer of 1,2-(diaminocyclohexane)AuClis preferably administered with a concentration ranging between about 10 μM and 20 μM.